"The transition from traditional pain administration to alternative options like conolidine features an avenue for safer treatment options during the realm of Persistent pain."Current trials clearly show promising outcomes, with patients reporting significant reductions in pain ranges. Scientists also emphasize the necessity for standardized dosing